Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH) (CLEVAS)

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified December 2013 by Henry Ford Health System
Sponsor:
Information provided by (Responsible Party):
Panayiotis Varelas, Henry Ford Health System
ClinicalTrials.gov Identifier:
NCT02011321
First received: December 2, 2013
Last updated: December 10, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: September 2015
  Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)